tert-Butyl 2-(methylthio)-7,8-dihydropyrido[4,3-d]pyrimidine-6(5H)-carboxylate, 97%, 1g

[1,2,4]Triazolo[1,5-a]pyrimidin-7-amine, 97.0%, 10g

3-(2,5-Dimethyl-1h-pyrrol-1-yl)propanoic acid, 97%, 5g

3-(5-Formyl-2,4-dimethyl-1H-pyrrol-3-yl)propanoic acid, 97.0%, 250mg

E-Plan-Phase EPLPHi 20x/0,40 unendlich korrigiertes IOS-Objektiv. Arbeitsabstand 2,61 mm

5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-ol, 95.0%, 5g

DIBENZO[B,D]FURAN-1-OL, 95.0%, 5g

2-(4-Bromophenylsulfonamido)acetic acid, 95.0%, 500g

2,4-Dibromo-6-fluorobenzoic acid, 97%, 1g

4-phenyl-3-(trifluoromethyl)-1H-pyrazol-5-amine hydrochloride, 95.0%, 250mg

(4-(Isopropylsulfonyl)phenyl)boronic acid, 95.0%, 5g

2-Bromodibenzo[b,d]furan-3-amine, 98%, 1g

(4S,5R)-2-(6-METHYLPYRIDIN-2-YL)-4,5-DIPHENYL-4,5-DIHYDROOXAZOLE, 95%, 50mg